ERNA vs WELL · P/E 0.0, rev $582.0K vs P/E 100, rev $10.84B
Eterna Therapeutics Inc (ERNA) versus Welltower Inc (WELL) — a side-by-side from cached financials, not a winner call.
Eterna Therapeutics Inc (ERNA) is a biotechnology company listed on NASDAQ.
Welltower Inc (WELL) is a reit - healthcare facilities company listed on NYSE.
Latest reported ERNA revenue for 2024-12-31 was $582.0K. Net income was -$44.5M. Revenue was up 755.9% from 2023-12-31 to 2024-12-31. ERNA currently screens at market cap $6.9M and trailing P/E 0.0.
Latest reported WELL revenue for 2025-12-31 was $10.84B. Net income was $936.8M. Revenue was up 35.6% from 2024-12-31 to 2025-12-31. WELL currently screens at market cap $145.81B and trailing P/E 99.8.
ERNA currently screens at market cap $6.9M and trailing P/E 0.0. WELL currently screens at market cap $145.81B and trailing P/E 99.8.
Not investment advice. Open the ERNA and WELL stock pages for the full models.
Not investment advice.